Orion Health boss must give up majority control to avoid Wynyard’s fate
"What's the point of having 50% of a declining company? It's better to have 25% of a well-capitalised one.”
Chris Keall Fri, 07 Apr 2017
This article canvasses, in part, whether Ian McCrae has been unwilling to yield majority control of Orion's shares. Another issue of control, whether he should step down as CEO and into a product innovation role, is discussed here. CK
Analysts approached by NBR say that, despite its cash
Want to read more? It's easy.
Choose your best value subscription option
Student
Exclusive offer for uni students studying at a New Zealand university (valued at $499).